Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Comment by vestor111 on Jun 18, 2020 9:18am
I like where this is going.. In addition, immunogenic cell death (ICD) caused by PDT releases damageassociated molecular patterns (DAMPs) that activate innate immunity, which leads to activation of adaptive immunity (8, 9). Henderson et al . have shown that PDT regimens can be developed to activate antitumor immunity (5). Multiple studies have linked PDTinduced acute inflammation ...more  
Comment by vestor111 on Jun 18, 2020 9:51am
Bummer I see no TLT/Rutherrin related research or researchers in the references. The author S. O. Gollnick appears a very prolific author in this field. Roswell Park CCC in Buffalo has been mentioned as an ideal partner for the TLT Ph2 trial in the US and not far from Toronto.  
Comment by CAinPlap on Jun 18, 2020 10:31am
Yes it is somewhat disappointing we do not seem to even be on the radar within our own scinetific community.
Comment by CAinPlap on Jun 18, 2020 10:35am
Sorry that should read scientific.  Getting tired of being the Rodney Dangerfield of the PDT space. We need to get the trials going so that more data can get the buzz going.
Comment by Eoganacht on Jun 18, 2020 12:15pm
I'm guessing there will need to be some catch-up in 18 months or so, by those who do not yet have TLD-1433 pdt on their radar. May I suggest... Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 TLD-1433 photodynamic therapy for BCG-unresponsive NMIBC - Presented by: Girish S. Kulkarni, ...more  
Comment by LaserStock29 on Jun 18, 2020 12:25pm
Are we 18 months away from breaking the .20 to .60 rangebound games or will the TMO 6 hospitals, fast track... nova scotia (another day of no cases btw) maybe some interim interim be enough to crack 20% of a 20% of a 4b bladder cancer market......... 200m cap
Comment by Hempdoc on Jun 18, 2020 12:49pm
  You read my mind ; ) The IT brigade wants the public to think of PDT as a potential adjuvant to IT, or even delineate IT/checkpoint blockade as a "much-eeded" adjuvant to PDT.  However, your last reference re: RuVaCare highlights why we could replace IT altogether.  Our anti-cancer vaccine demonstrated an excellent survival rate in the rat glioma model, & as you ...more  
Comment by Hempdoc on Jun 18, 2020 1:19pm
  To clarify the value of what we have...TLT has created an arsenal of therapeutic options to fight cancer.  We have our patented frontlines in TLD-1433, newer TLD derivatives, optimized PDT & possibly other forms of activation (x-ray, etc) & also our promising reserves consisting of sequential PDT/other activators +/- serial vaccination.  Now that's a one-two punch ...more  
Comment by vestor111 on Jun 18, 2020 2:03pm
and patents that cover the waterfront.  
Comment by Quattro74 on Jun 18, 2020 3:16pm
Yes and not just Cad & US patents. Hey don't we Have an FDA IND going on? Lol. So what IT is out there? Keytruda? I think its durable CR % maxes at ~ 30% depending on the indication. Hmmm, yep. No brainer Home Run!
Comment by CAinPlap on Jun 18, 2020 5:35pm
Yup we are hitting home runs in spring training batting practice where no one sees it but the training staff. We need the regular season to start where the games are televised, fans in the stands and post game coverage by the media. Based on our spring training results, we should be World Series favorites! ;) This analogy brought to you by the sports fan withdrawal support group.
Comment by Quattro74 on Jun 18, 2020 10:43pm
Yep, definetely withdrawals. MLB is a bad omen for TLT right now. :-( Once ~ 50-60 patients have their 90 day CR data in and the first few of the 12 have their 1Yr CR data, should get interesting for SP. Especially since a good cunk of those patients will be US based.  $$$
Comment by O12009 on Jun 19, 2020 6:34am
It's time to put the rally caps on
Comment by menoalittle on Jun 19, 2020 10:42am
>> It's time to put the rally caps on yeah, well... sellers sure do appear to be exhausted. ... but buyers are also tired as all 'ell (which I'll attest to...) so I don't know what it's time for.   ...the weekend, evidently. Must be five o'clock somewhere... (or somethings like that...) pour me another one... lol.
Comment by langosta1 on Jun 19, 2020 11:47am
When in need of a bit of, 'Hair of the dog" there is an old sailor expression. "Somewhere the sun is over the yardarm"  (Noon hour). So I'll drink to that. 
Comment by StevenBirch on Jun 19, 2020 11:46am
Yes definitely feeling sports withdrawal instead settling for reruns of classic, and some not so classic games. While before my time baseball fans will remember Bobby Thomson's 'shot heard 'round the world' and maybe that will be TLT sooner rather than later. Everything seems to be falling into place and it's just a matter of when and not if - I think there is almost zero ...more  
Comment by vestor111 on Jun 18, 2020 2:01pm
So much of a homerun, some big pharma cos who bet big time on IT might have to change their underwear.   One, two, three, four, I declare a bidding war.  :-)  
Comment by Hempdoc on Jun 18, 2020 11:36am
  I would say the article is just a reflection of the ACT era we find ourselves in....this B rated movie stars immunotherapy, not PDT.  PDT acts as the extra or "adjuvant" to immune checkpoint blockade. Again, the immunotherapy brigade got it backwards. Sure, PDT can work as a nice adjuvant if your photosensitizer is NOT TLD-1433.  The beauty of TLD-1433 is in its ...more  
Comment by NorCalTommy on Jun 18, 2020 11:31pm
thanks Enriquesuave!  wow.... my eyes are glazed over after reading all of that -'as a layman '   I guess to boil it down it says in so many words that PDT has been around for awhile and much research has been done in the last few years and that research is encouraging, etc. etc....   very encouraging....  but it just seems like TLT moves at about 1/2 pace of ...more  
Comment by skyhawk1 on Jun 18, 2020 11:46pm
Look for 2020-2021 FIREWORKS, if we RESUME & "GET CRACKING" soon in the good 'ole US of A!! Canadian data results will start the "ball rolling" & the US results will get us "fast track"!  
Comment by vestor111 on Jun 19, 2020 7:46am
TLT is dealing with layer upon layer of bureaucracy and regulation so yeah it is slooooooow.  But I think/hope we get noticed and rolling long before 2025...  But having said that, I wonder how many indications will be pursued at that point?  I would think if GBM - for example get announced this year and due to the nature of that death sentence gets trialed with urgency with ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250